Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its ...
Abstract: This study addresses the problem of generalized category discovery (GCD), an advanced and challenging semi-supervised learning scenario that deals with unlabeled data from both known and ...
Abstract: Generalized category discovery (GCD) aims to classify instances into both known and previously unseen categories, posing a challenge for traditional classification systems constrained by ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果